A&M works in Interim Management and Advisory roles to support the Office of the CFO across a wide range of healthcare businesses and situations, helping support not only the basic functionality of the finance department, but transforming it to an important business partner to the executive team, investors and other key constituents.
Whether an organization is scaling from a founder led business, going through a large acquisition, seeking to manage costs or building reporting capabilities, A&M can provide the right support to accelerate improvements in the finance organization.
Rely on us for help with:
- Interim CFO
- Accounting, including Cash to Accrual
- Financial Reporting, Dashboards and KPIS
- Financial Systems and Information Technology
- Forecasting, Planning and Analysis
- Treasury
- Strategic Procurement to Payables
- Merger integrations and synergy capture
- Revenue Cycle Management
- Finance organizational design and benchmarking
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
The Effect of Trump’s Tariffs on the European Pharmaceutical and Biopharmaceutical Industry
June 9, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could
be felt across the global healthcare landscape.
FORMER FEDERAL HEALTH MINISTER PROFESSOR GREG HUNT JOINS ALVAREZ & MARSAL AUSTRALIA
May 27, 2025
Alvarez & Marsal appoints The Honourable Greg Hunt as a Senior Advisor bolstering its Healthcare and Public Sector advisories in support of maximizing sustainable value for clients.
Contract Research Organisations M&A Market
March 28, 2025
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
